Category: Biotech

1 2 10 / 15 POSTS
Nearing the end of its long running Phase III trial for squamous cell carcinoma of the head and neck (SCCHN), CEL-SCI has experienced several recent catalysts that have returned attention and interest to their novel immuno-oncology program. In Ju ...
Consumer genetic testing has now reached a point where it is affordable to the individual user. However, patients’ valuable, private data is typically help by third-party organisations, which make money with this data without involving the donor. ...
Headquartered in Phoenix, Arizona, Axolotl Biologix is focused on researching to optimize the use of human biologicals and to develop biological-related products that will foster regeneration and healing for many conditions that affect patients. ...
43-year old Lance Bennett and his partner launched Advanced Genomic Solutions (AGS) in 2015 to empower individuals and physicians to make more informed decisions about overall health based on genetics. His DNA testing company is headquartered in ...
InSitu Biologics is an emerging biotech company focusing on development of AnestaGel™, a long-lasting and long-acting non-opiate painkiller. The sustained release drug AnestaGel is expected to be used in post-operative surgical procedures. Anesta ...
Precision Biosciences is a gene editing company that was able to raise $110 million in June. They are using what is called a homing endonuclease which can potentially recognize very specific DNA sequences and replace them with new DNA sequences. ...
Allogene Therapeutics, Grail, Brii BioSciences, Moderna Therapeutics, Precision BioSciences, Kaleido Biosciences, Constellation Pharmaceuticals, Stealth BioTherapeutics, PACT Pharma, Beam Therapeutics. Healthcare was 15% of total deal activity i ...
Dr. Todd Malan is an internationally recognized Stem Cell Pioneer and leading expert in the field of regenerative medicine. He was the first US physician to perform a stem cell breast augmentation in 2009. He is an innovator and leading expert in ...
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Financial UpdateOn July 23, 2018, MediciNova, Inc. (NASDAQ:MNOV) filed form 10-Q with financial results for the second quarter of 2018. As expected, the company did not report any rev ...
By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Financial UpdateOn July 23, 2018, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) announced financial results for the second quarter of 2018 and provided a business update. As expect ...
1 2 10 / 15 POSTS